Oxford/AstraZeneca: Vaxzevria

Vaccine Type: Non Replicating Viral Vector

This vaccine may also be referred to as AZD1222, ChAdOx1 nCoV-19

Vaccine Trial & Approval Tracker

This vaccine is approved.

About Trial Phases

Phase 1: 10 Trials

Phase 2: 36 Trials

Phase 3: 17 Trials

This vaccine is also manufactured by the Serum Institute of India (Covishield)

Registered Trials